About DaBomb Protein
DaBomb Protein is a company based in Tainan (Taiwan) founded in 2001.. The company has 46 employees as of December 31, 2024. DaBomb Protein operates in a competitive market with competitors including Pharmaron, Pfizer, Boehringer Ingelheim, Lonza and Dotmatics, among others.
- Headquarter Tainan, Taiwan
- Employees 46 as on 31 Dec, 2024
- Stage Public
-
Sectors
AgricultureHealthcare Consumer
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Dabomb Protein Biotech Corporation
-
Annual Revenue
$0 (USD)-12.12as on Dec 31, 2024
-
Net Profit
$0 (USD)120.41as on Dec 31, 2024
-
EBITDA
$0 (USD)244.7as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
46
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of DaBomb Protein
DaBomb Protein is a publicly listed company on the TPEX with ticker symbol 6578 in Taiwan, operating in the Consumer non-durables sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of DaBomb Protein
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by DaBomb Protein
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - DaBomb Protein
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Dabomb Protein Comparisons
Competitors of DaBomb Protein
DaBomb Protein operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Pfizer, Boehringer Ingelheim, Lonza and Dotmatics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug discovery and development services for small molecules are provided.
|
|
| domain | founded_year | HQ Location |
Pharmaceutical products for treating multiple diseases are provided.
|
|
| domain | founded_year | HQ Location |
Generic drugs and clinical research services are provided globally.
|
|
| domain | founded_year | HQ Location |
CDMO services for pharma, biotech, and specialty ingredients are provided.
|
|
| domain | founded_year | HQ Location |
AI powered scientific data management and workflow automation solutions
|
|
| domain | founded_year | HQ Location |
Laboratory testing, clinical trial research, and biopharma services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Dabomb Protein
Frequently Asked Questions about DaBomb Protein
When was DaBomb Protein founded?
DaBomb Protein was founded in 2001.
Where is DaBomb Protein located?
DaBomb Protein is headquartered in Tainan, Taiwan.
How many employees does DaBomb Protein have?
As of Dec 31, 2024, the latest employee count at DaBomb Protein is 46.
What does DaBomb Protein do?
DaBomb Protein, established in 2001 and currently in Public stage, focuses on producing consumer products, pet care products, food supplements, health supplements, and multi category. Manufacturer of protein food for pets. Adapting to market demands with innovation and client-focused strategies.
Who are the top competitors of DaBomb Protein?
Is DaBomb Protein publicly traded?
Yes, DaBomb Protein is publicly traded on TPEX under the ticker symbol 6578.
What is DaBomb Protein's ticker symbol?
The ticker symbol of DaBomb Protein is 6578 on TPEX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.